Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chalasani

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 27, 2025
Biological age, PNPLA3 and risk of metabolic dysfunction-associated steatotic liver diseaseSamer Gawrieh, Jie Yao, Xiuqing Guo, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Disrupted balance between pro-inflammatory lipid mediators and anti-inflammatory specialized pro-resolving mediators is linked to hyperinflammation in patients with alcoholic hepatitisWei Li, Ying Xia, Jing Yang, et al.
Journal of Clinical Gastroenterology|August 31, 2006
Autoimmune hepatitis triggered by statinsVamsee Alla, Joseph Abraham, Junaid Siddiqui, et al.
Transplantation|January 16, 2007
Complete reversal of glycogen hepatopathy with pancreas transplantation: two casesJonathan A Fridell, Romil Saxena, Naga P Chalasani, et al.
Frontiers in Immunology|December 6, 2024
Disrupted balance between pro-inflammatory lipid mediators and anti-inflammatory specialized pro-resolving mediators is linked to hyperinflammation in patients with alcoholic hepatitisWei Li, Ying Xia, Jing Yang, et al.
Plos One|October 10, 2014
Obesity associated molecular forms of C-reactive protein in humanBela F Asztalos, Michael S Horan, Katalin V Horvath, et al.
Journal of the American College of Cardiology|March 2, 2019
Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art ReviewEric P Stahl, Devinder S Dhindsa, Suegene K Lee, et al.
The American Journal of Gastroenterology|June 18, 2014
ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injuryNaga P Chalasani, Paul H Hayashi, Herbert L Bonkovsky, et al.
Gastroenterology|May 27, 2020
ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol ConsumptionEduardo Vilar-Gomez, Silvia Sookoian, Carlos Jose Pirola, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|June 30, 2024
The athero-contour: A novel tool for global and rapid assessment of atherogenic parameters. A use case in saroglitazar treatment of MAFLD patientsKung-Hung Lin, Nuria Amigo, Pablo Ortiz, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 27, 2025
Biological age, PNPLA3 and risk of metabolic dysfunction-associated steatotic liver diseaseSamer Gawrieh, Jie Yao, Xiuqing Guo, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Disrupted balance between pro-inflammatory lipid mediators and anti-inflammatory specialized pro-resolving mediators is linked to hyperinflammation in patients with alcoholic hepatitisWei Li, Ying Xia, Jing Yang, et al.
Journal of Clinical Gastroenterology|August 31, 2006
Autoimmune hepatitis triggered by statinsVamsee Alla, Joseph Abraham, Junaid Siddiqui, et al.
Transplantation|January 16, 2007
Complete reversal of glycogen hepatopathy with pancreas transplantation: two casesJonathan A Fridell, Romil Saxena, Naga P Chalasani, et al.
Frontiers in Immunology|December 6, 2024
Disrupted balance between pro-inflammatory lipid mediators and anti-inflammatory specialized pro-resolving mediators is linked to hyperinflammation in patients with alcoholic hepatitisWei Li, Ying Xia, Jing Yang, et al.
Plos One|October 10, 2014
Obesity associated molecular forms of C-reactive protein in humanBela F Asztalos, Michael S Horan, Katalin V Horvath, et al.
Journal of the American College of Cardiology|March 2, 2019
Nonalcoholic Fatty Liver Disease and the Heart: JACC State-of-the-Art ReviewEric P Stahl, Devinder S Dhindsa, Suegene K Lee, et al.
The American Journal of Gastroenterology|June 18, 2014
ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injuryNaga P Chalasani, Paul H Hayashi, Herbert L Bonkovsky, et al.
Gastroenterology|May 27, 2020
ADH1B∗2 Is Associated With Reduced Severity of Nonalcoholic Fatty Liver Disease in Adults, Independent of Alcohol ConsumptionEduardo Vilar-Gomez, Silvia Sookoian, Carlos Jose Pirola, et al.
Clinica E Investigacion En Arteriosclerosis : Publicacion Oficial De La Sociedad Espanola De Arteriosclerosis|June 30, 2024
The athero-contour: A novel tool for global and rapid assessment of atherogenic parameters. A use case in saroglitazar treatment of MAFLD patientsKung-Hung Lin, Nuria Amigo, Pablo Ortiz, et al.
Pageof 10